Southern Acids (M) Berhad Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Southern Acids (M) Berhad şirketinin kazançları yıllık ortalama -4% oranında azalırken, Chemicals sektörünün kazançları yıllık 4.8% oranında artan oldu. Gelirler yıllık ortalama 11.4% oranında artan oldu. Southern Acids (M) Berhad şirketinin öz sermaye getirisi 1.8% olup, net marjı 0.7% dir.

Anahtar bilgiler

-4.0%

Kazanç büyüme oranı

-4.0%

EPS büyüme oranı

Chemicals Sektör Büyümesi	8.9%
Gelir büyüme oranı	11.4%
Özkaynak getirisi	1.8%
Net Marj	0.7%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Mar 03

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

May 27

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Apr 19

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Feb 24

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

Jan 13

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

Dec 15

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

Nov 24

Gelir ve Gider Dağılımı

Southern Acids (M) Berhad nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

KLSE:SAB Gelir, gider ve kazançlar (MYR Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	946	6	82
31 Mar 24	920	14	82
31 Dec 23	934	-1	79
30 Sep 23	977	11	63
30 Jun 23	1,025	28	64
31 Mar 23	1,107	33	81
31 Dec 22	1,222	69	91
30 Sep 22	1,253	80	105
30 Jun 22	1,220	86	101
31 Mar 22	1,181	94	77
31 Dec 21	1,039	74	73
30 Sep 21	918	53	71
30 Jun 21	846	44	71
31 Mar 21	746	37	69
31 Dec 20	704	40	58
30 Sep 20	690	44	59
30 Jun 20	682	44	61
31 Mar 20	666	32	62
31 Dec 19	627	24	57
30 Sep 19	602	19	57
30 Jun 19	588	19	56
31 Mar 19	604	21	56
31 Dec 18	658	29	59
30 Sep 18	711	35	57
30 Jun 18	747	32	55
31 Mar 18	767	33	56
31 Dec 17	787	41	56
30 Sep 17	780	44	55
30 Jun 17	752	47	54
31 Mar 17	740	49	51
31 Dec 16	646	37	45
30 Sep 16	579	29	45
30 Jun 16	548	23	47
31 Mar 16	503	25	47
31 Dec 15	479	27	48
30 Sep 15	490	30	48
30 Jun 15	507	30	49
31 Mar 15	537	28	50
31 Dec 14	575	29	51
30 Sep 14	585	31	51
30 Jun 14	565	38	49
31 Mar 14	544	38	48
31 Dec 13	539	39	42

Kaliteli Kazançlar: SAB yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: SAB 'nin mevcut net kar marjları (0.7%) geçen yılın (2.7%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: SAB şirketinin kazançları son 5 yılda yılda 4% oranında azaldı.

Büyüme Hızlandırma: SAB 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: SAB geçtiğimiz yıl negatif kazanç büyümesine ( -77.6% ) sahipti ve bu da onu Chemicals sektör ortalamasıyla ( 9.1% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: SAB 'nin Özsermaye Getirisi ( 1.8% ) düşük olarak değerlendiriliyor.

Southern Acids (M) Berhad Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Third quarter 2024 earnings released: EPS: RM0.033 (vs RM0.12 in 3Q 2023)

Second quarter 2024 earnings released: RM0.039 loss per share (vs RM0.081 profit in 2Q 2023)

First quarter 2024 earnings released: EPS: RM0.067 (vs RM0.11 in 1Q 2023)

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Recent updates

New minor risk - Market cap size

Upcoming dividend of RM0.05 per share

New major risk - Revenue and earnings growth

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad, Annual General Meeting, Aug 26, 2024

New minor risk - Market cap size

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Third quarter 2024 earnings released: EPS: RM0.033 (vs RM0.12 in 3Q 2023)

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad (KLSE:SAB) entered into agreement to acquire remaining 10% stake in Firstview Development Sdn Bhd from Low Mong Hua Sdn Berhad for RM 23.5 million.

Second quarter 2024 earnings released: RM0.039 loss per share (vs RM0.081 profit in 2Q 2023)

Upcoming dividend of RM0.05 per share at 1.5% yield

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

First quarter 2024 earnings released: EPS: RM0.067 (vs RM0.11 in 1Q 2023)

New minor risk - Market cap size

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Outhern Acids (M) Berhad Recommends Single Tier Final Dividend in Respect of the Financial Year Ended 31 March 2023

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Third quarter 2023 earnings released: EPS: RM0.12 (vs RM0.20 in 3Q 2022)

Second quarter 2023 earnings released: EPS: RM0.082 (vs RM0.13 in 2Q 2022)

Price target decreased to RM3.40

Insufficient new directors

Upcoming dividend of RM0.05 per share

Full year 2022 earnings released: EPS: RM0.69 (vs RM0.27 in FY 2021)

Southern Acids (M) Berhad Announces Final Dividend, Payable on 28 Nov. 2022

Southern Acids (M) Berhad Recommends Single Tier Final Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to RM3.40

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

First quarter 2022 earnings released: EPS RM0.17 (vs RM0.13 in 1Q 2021)

Upcoming dividend of RM0.05 per share

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

Price target decreased to RM3.40

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

Southern Acids (M) Berhad Recommends Final Dividend for the Year Ended March 31, 2021

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Third quarter 2021 earnings released: EPS RM0.041 (vs RM0.076 in 3Q 2020)

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

New 90-day high: RM3.88

Southern Acids (M) Berhad Announces Appointment of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Ember of Audit Committee

Second quarter 2021 earnings released: EPS RM0.06

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

New 90-day high: RM3.80

Southern Acids (M) Berhad Announces the Resignation of Encik Teo Leng as Independent and Non Executive Member of Audit Committee

New 90-day high: RM3.72

Upcoming Dividend of RM0.05 Per Share

First quarter earnings released

New 90-day high - RM3.68

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin